C. Paul, P. Wolkenstein, and H. Adle, Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis, British Journal of Dermatology, vol.91, issue.4, pp.710-724, 1996.
DOI : 10.1016/0167-5699(94)90249-6

I. Viard, P. Wehrli, and R. Bullani, Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin, Science, vol.282, issue.5388, pp.490-493, 1998.
DOI : 10.1126/science.282.5388.490

A. Nassif, A. Bensussan, and L. Boumsell, Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells, Journal of Allergy and Clinical Immunology, vol.114, issue.5, pp.1209-1224, 2004.
DOI : 10.1016/j.jaci.2004.07.047

A. Janin, C. Deschaumes, and M. Daneshpouy, CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications, Blood, vol.99, issue.8, pp.2940-2947, 2002.
DOI : 10.1182/blood.V99.8.2940

C. Deschaumes, L. Verneuil, and M. Ertault-daneshpouy, CD95 ligand-dependent endothelial cell death initiates oral mucosa damage in a murine model of acute graft versus host disease, Lab Invest, vol.87, pp.417-446, 2007.

M. Ertault-daneshpouy, C. Leboeuf, and M. Lemann, Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease, Blood, vol.103, issue.12, pp.4681-4685, 2004.
DOI : 10.1182/blood-2003-05-1548

H. Murata, A. Janin, and C. Leboeuf, Donor-derived cells and human graft-versus-host disease of the skin, Blood, vol.109, issue.6, pp.2663-2668, 2007.
DOI : 10.1182/blood-2006-07-033902

Y. Gavrieli, Y. Sherman, and S. Ben-sasson, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, The Journal of Cell Biology, vol.119, issue.3, pp.493-501, 1992.
DOI : 10.1083/jcb.119.3.493

J. Timsit, G. Mion, and N. Rouyer, Bronchopulmonary distress associated with toxic epidermal necrolysis, Intensive Care Medicine, vol.324, issue.1, pp.42-46, 1992.
DOI : 10.1007/BF01706425

O. Chosidow, J. Delchier, and M. Chaumette, Intestinal involvement in drug-induced toxic epidermal necrolysis, The Lancet, vol.337, issue.8746, p.928, 1991.
DOI : 10.1016/0140-6736(91)90273-R

M. Masia, F. Gutierrez, and A. Jimeno, Fulminant Hepatitis and Fatal Toxic Epidermal Necrolysis (Lyell Disease) Coincident With Clarithromycin Administration in an Alcoholic Patient Receiving Disulfiram Therapy, Archives of Internal Medicine, vol.162, issue.4, pp.474-480, 2002.
DOI : 10.1001/archinte.162.4.474

P. Paquet, A. Nikkels, and J. Arrese, Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis, Archives of Dermatology, vol.130, issue.5, pp.605-613, 1994.
DOI : 10.1001/archderm.130.5.605

J. Murata, R. Abe, and H. Shimizu, Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment, Journal of Allergy and Clinical Immunology, vol.122, issue.5, pp.992-1000, 2008.
DOI : 10.1016/j.jaci.2008.06.013

A. Haimovitz-friedman, C. Cordon-cardo, and S. Bayoumy, Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation, The Journal of Experimental Medicine, vol.2, issue.11, pp.1831-1872, 1997.
DOI : 10.1073/pnas.93.9.4504

J. Choy, R. Cruz, and A. Kerjner, Granzyme B Induces Endothelial Cell Apoptosis and Contributes to the Development of Transplant Vascular Disease, American Journal of Transplantation, vol.169, issue.3, pp.494-503, 2005.
DOI : 10.1038/35003221